Why should I store my child’s stem cells?

Professor Peter Hollands, WideCell’s Group Chief Scientific Officer, comments on unethical and unproven stem cell “therapies” and advises on how to sort the snake oil promises from the genuine science: The early 21st century offers some

Protect your family and ensure your medical wealth for generations to come. Umbilical cord blood stem cell transplantation has increased by 300% over the last 13 years globally thanks to their use to treat over 80 different blood

What is Essential Thrombocythaemia? Essential Thrombocythaemia is a rare blood disorder caused by an overproduction of megakaryocytes, the cells responsible for making platelets in our bone marrow. Essential Thrombocythaemia is a myeloproliferative neoplasm, part of a

Stem cell transplantation is a complex process. However, the transplant procedure itself is straightforward, similar in fact to a blood transfusion. The donor stem cells are transfused through a central line (a catheter) which goes into

In response to the use of embryonic stem cells to restore vision in two patients with macular degeneration, WideCells Group CSO Professor Peter Hollands provides insight into the history – and his personal experience of — this controversial

A new review highlights the recent advances in grafting human stem cells into tissue engineering to repair and regenerate human body parts. Stem cell research possesses great potential for the advancement of medicine, therapy, and human

What is Hermanksy-Pudlak Syndrome? Hermansky-Pudlak Syndrome (HPS) is a rare disease characterised by an absence of pigment in the skin, eyes and hair known as oculocutaneous albinism. These individuals have extreme sensitivity to the sun and

What is Pure Red Cell Aplasia? Pure Red Cell Aplasia or erythroblastopenia is a form of anaemia, a blood disorder caused by a reduction in the number of red blood cells. There are many different forms

Widecells Group PLC CSO Peter Hollands gives his view on new work aimed at using stem cells to create personalised drugs for treatment of mental illnesses: The article is based on research into the use of stem

Investments that ensure the future WideCells Group’s mission is to make stem cell therapies globally accessible. The group consists of 3 divisions. CellPlan: the world’s first stem cell healthcare insurance plan with financial cover for medical

Professor Peter Hollands, WideCells Group Chief Scientific Officer, gives an overview of the principles of Regenerative Medicine: Regenerative Medicine is nothing new. It has been practised since the first bone marrow transplant in the 1950s to

What is Non-Hodgkins Lymphoma? Non-Hodgkin’s Lymphoma is a cancer of the blood. It begins in a subset of white blood cells called lymphocytes. Lymphocytes are either B-cells (responsible for making antibodies to fight viruses) or T-cells,

Olivia Rezek MSc AMRSB, a Laboratory Scientist at WideCells, reviews the latest research into blood vessel cells, known as vascular endothelial cells (VECs), a subset of which are stem cells (VESCs): CD157 Marks Tissue-Resident Endothelial Stem

Olivia Rezek MSc AMRSB, a Laboratory Scientist at WideCells, reviews the latest research into a gene mutation which results in an abnormal number of DNA sequence repeats: G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and